Michael E. LeTourneau

478 total citations
20 papers, 322 citations indexed

About

Michael E. LeTourneau is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Michael E. LeTourneau has authored 20 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 9 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Michael E. LeTourneau's work include Chemical Synthesis and Analysis (4 papers), Nitric Oxide and Endothelin Effects (2 papers) and Analytical Chemistry and Chromatography (2 papers). Michael E. LeTourneau is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Nitric Oxide and Endothelin Effects (2 papers) and Analytical Chemistry and Chromatography (2 papers). Michael E. LeTourneau collaborates with scholars based in United States. Michael E. LeTourneau's co-authors include James R. McCarthy, Norton P. Peet, Bret E. Huff, Jeffrey A. Ward, Michael A. Staszak, Kevin A. Sullivan, Michael J. Martinelli, Charles J. Barnett, Margaret M. Faul and Thomas Wilson and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Michael E. LeTourneau

20 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. LeTourneau United States 11 232 100 87 34 30 20 322
Matthew M. Zhao United States 11 449 1.9× 168 1.7× 77 0.9× 30 0.9× 71 2.4× 15 554
Alcide Perboni Italy 13 365 1.6× 82 0.8× 20 0.2× 22 0.6× 57 1.9× 31 447
Shin Chung South Korea 9 275 1.2× 95 0.9× 49 0.6× 20 0.6× 11 0.4× 17 364
Markus Furegati Switzerland 6 225 1.0× 54 0.5× 35 0.4× 22 0.6× 38 1.3× 12 274
Brian Kotecki United States 12 342 1.5× 78 0.8× 17 0.2× 28 0.8× 60 2.0× 20 409
Janice E. Sieser United States 12 520 2.2× 100 1.0× 80 0.9× 18 0.5× 102 3.4× 16 574
James A. Profitt United States 10 146 0.6× 156 1.6× 15 0.2× 86 2.5× 23 0.8× 16 368
Jeffrey M. Kallemeyn United States 11 354 1.5× 63 0.6× 48 0.6× 37 1.1× 37 1.2× 19 425
Deidre L. Sandrock United States 10 785 3.4× 114 1.1× 49 0.6× 23 0.7× 96 3.2× 11 832
Alexandre L’Heureux United States 9 430 1.9× 224 2.2× 344 4.0× 21 0.6× 137 4.6× 12 610

Countries citing papers authored by Michael E. LeTourneau

Since Specialization
Citations

This map shows the geographic impact of Michael E. LeTourneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. LeTourneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. LeTourneau more than expected).

Fields of papers citing papers by Michael E. LeTourneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. LeTourneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. LeTourneau. The network helps show where Michael E. LeTourneau may publish in the future.

Co-authorship network of co-authors of Michael E. LeTourneau

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. LeTourneau. A scholar is included among the top collaborators of Michael E. LeTourneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. LeTourneau. Michael E. LeTourneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frederick, Michael O., Joel R. Calvin, Michael E. LeTourneau, et al.. (2015). Development of an NH4Cl-Catalyzed Ethoxy Ethyl Deprotection in Flow for the Synthesis of Merestinib. Organic Process Research & Development. 19(10). 1411–1417. 15 indexed citations
2.
Frederick, Michael O., Scott A. Frank, Jeffrey T. Vicenzi, et al.. (2014). Development of a Hydrogenative Reductive Amination for the Synthesis of Evacetrapib: Unexpected Benefits of Water. Organic Process Research & Development. 18(4). 546–551. 8 indexed citations
3.
Waser, Mario, Eric D. Moher, Marvin M. Hansen, et al.. (2011). Process Development for a Key Synthetic Intermediate of LY2140023, a Clinical Candidate for the Treatment of Schizophrenia. Organic Process Research & Development. 15(6). 1266–1274. 20 indexed citations
4.
Braden, Timothy M., Donald S. Coffey, Christopher W. Doecke, et al.. (2007). A Convergent Kilogram-Scale Synthesis of the PPARα Agonist LY518674:  Discovery of a Novel Acid-Mediated Triazolone Synthesis. Organic Process Research & Development. 11(3). 431–440. 5 indexed citations
5.
Magnus, Nicholas A., James Aikins, Michael E. LeTourneau, et al.. (2005). Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator. Organic Process Research & Development. 9(5). 621–628. 13 indexed citations
7.
Faul, Margaret M., Thomas A. Engler, Kevin A. Sullivan, et al.. (2004). Synthetic Approaches to Indolo[6,7-a]pyrrolo[3,4-c]carbazoles:  Potent Cyclin D1/CDK4 Inhibitors. The Journal of Organic Chemistry. 69(9). 2967–2975. 31 indexed citations
8.
Xu, Yao‐Chang, Kirk W. Johnson, Lee A. Phebus, et al.. (2001). N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide:  A Potent, Selective, and Orally Active 5-HT1F Receptor Agonist Potentially Useful for Migraine Therapy. Journal of Medicinal Chemistry. 44(24). 4031–4034. 19 indexed citations
9.
Horgan, Stephen W., Robert J. Cregge, Michael E. LeTourneau, et al.. (1999). Process Development in the Synthesis of the ACE Intermediate MDL 28,726. Organic Process Research & Development. 3(4). 241–247. 6 indexed citations
10.
Hansen, Marvin M., Allen R. Harkness, Bret E. Huff, et al.. (1998). An Enantioselective Synthesis of Cis Perhydroisoquinoline LY235959. The Journal of Organic Chemistry. 63(3). 775–785. 19 indexed citations
11.
Faul, Margaret M., Bret E. Huff, Scott A. Frank, et al.. (1997). Synthesis of 2′,3′-dideoxy-3′-hydroxymethylcytidine; a unique antiviral nucleoside. Tetrahedron. 53(24). 8085–8104. 19 indexed citations
12.
Stille, John R., et al.. (1997). Synthetic Approaches to Benzofuran Containing Insulin Sensitivity Enhancer Compounds for Treatment of Type II Diabetes. Heterocycles. 45(7). 1363–1363. 4 indexed citations
13.
Huff, Bret E., et al.. (1997). Diastereoselectivity in the heterogeneous hydrogenation reactions of phosphorous substituted olefins. Tetrahedron Letters. 38(50). 8627–8630. 6 indexed citations
14.
Huff, Bret E., Michael E. LeTourneau, Michael A. Staszak, & Jeffrey A. Ward. (1996). Protection, metalation, and electrophilic substitution of 5-methyl tetrazole. Tetrahedron Letters. 37(21). 3655–3658. 20 indexed citations
15.
Peet, Norton P. & Michael E. LeTourneau. (1991). Synthesis of Angular Benzodipyrazoles and Related Systems. Heterocycles. 32(1). 41–41. 9 indexed citations
16.
Peet, Norton P., James W. Malecha, Michael E. LeTourneau, & Shyam Sunder. (1989). Preparation of imidazo[2,1‐b]quinazolin‐5(3H)‐ones and related tricyclic systems using a novel, double displacement reaction. Journal of Heterocyclic Chemistry. 26(1). 257–264. 9 indexed citations
17.
LeTourneau, Michael E. & Norton P. Peet. (1987). Functionalized pyrazoles from indazol-4-ols. The Journal of Organic Chemistry. 52(19). 4384–4387. 5 indexed citations
18.
McCarthy, James R., et al.. (1985). (Diethylamino)sulfur trifluoride in organic synthesis. 2. The transformation of sulfoxides to .alpha.-fluoro thioethers. Journal of the American Chemical Society. 107(3). 735–737. 71 indexed citations
19.
McCarthy, James R., Mark Zimmerman, Michael E. LeTourneau, et al.. (1985). 6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-Phenoxycylopentyl)amino]methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel .alpha.1-adrenergic receptor antagonist and renal vasodilator. Journal of Medicinal Chemistry. 28(9). 1142–1145. 2 indexed citations
20.
LeTourneau, Michael E. & James R. McCarthy. (1984). A novel synthesis of α-fluoroacetonitriles. Application to a convenient preparation of 2-fluoro-2-phenethylamines. Tetrahedron Letters. 25(46). 5227–5230. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026